# UHS MARKET DATA SUMMARY

**Date Retrieved:** October 27, 2025
**Status:** ‚úÖ All Market Data Collected

---

## üìà CURRENT MARKET VALUATION

### UHS Stock Price & Market Cap

| Metric | Value | Source |
|--------|-------|--------|
| **Current Stock Price** | **$208.39** | NYSE (Oct 27, 2025) |
| **52-Week High** | $243.25 | Market data |
| **52-Week Low** | $152.33 | Market data |
| **Market Capitalization** | **$13.39B** | Calculated |
| **Shares Outstanding** | 64.98M | From 10-K |

**Price Performance:**
- YTD: +36.7% (estimated from 52-week range)
- Stock trading near mid-range of 52-week band

---

### Calculated Enterprise Value

```
Market Capitalization:           $13.39B
  + Total Debt:                  $ 4.50B
  - Cash:                        $ 0.13B
‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ
= ENTERPRISE VALUE:              $17.76B
```

---

### Current Trading Multiples

| Multiple | Calculation | Value |
|----------|-------------|-------|
| **P/E Ratio** | $208.39 / $16.82 EPS | 12.4x |
| **Price / Book** | $208.39 / $102.59 Book Value | 2.0x |
| **EV / Revenue** | $17.76B / $15.83B | 1.12x |
| **EV / EBITDA** | $17.76B / $2.78B | **6.4x** |
| **Market Cap / Equity** | $13.39B / $6.67B | 2.0x |
| **Net Debt / EBITDA** | $4.38B / $2.78B | 1.58x |

---

## üè• COMPARABLE COMPANY MULTIPLES

### Behavioral Health Pure-Play

**Acadia Healthcare (ACHC)**
- **EV/EBITDA:** 7.3x (primary source) / 6.6x (secondary source)
- **Market Cap:** $2.2B
- **Enterprise Value:** $4.4B
- **2025 EBITDA Guidance:** $675-$725M
- **Implied Multiple Range:** 6.1x - 6.6x on 2025 EBITDA
- **Notes:** Stock down 25% after weak Q4 2024, conservative 2025 guidance
- **Quality:** Pure-play behavioral, direct comp to UHS behavioral segment

**Recommended Multiple for UHS Behavioral:** **8.0-10.0x** (ACHC at 7.3x, but ACHC is currently depressed; historical range 9-12x)

---

### Acute Care Hospital Comparables

**Tenet Healthcare (THC)**
- **EV/EBITDA:** 6.3x
- **Market Cap:** $18.0B
- **2025 EBITDA Guidance:** $4.4-$4.54B
- **Performance:** Strong 2025 (+62% YTD), raised guidance
- **Trading:** 18% discount to 5-year historical average
- **Quality:** Direct comp to UHS acute care

**HCA Healthcare (HCA)** - Premium Operator
- **EV/EBITDA:** 9.0-10.1x
- **Trailing EBITDA:** $14.5B
- **Quality:** Industry leader, premium multiple justified
- **Notes:** Trades at 50-60% premium to Tenet

**Hospital Industry Average:** 8.14x EV/EBITDA

**Recommended Multiple for UHS Acute Care:** **6.5-8.0x** (THC at 6.3x, industry avg 8.1x)

---

### Healthcare REIT Cap Rates

**Healthpeak Properties (DOC)**
- **Implied Cap Rate:** 7.4%
- **Dividend Yield:** 5.88%
- **Focus:** Medical office buildings, hospitals, life sciences
- **Quality:** Largest healthcare REIT

**Sabra Health Care REIT (SBRA)**
- **Dividend Yield:** 6.95%
- **Focus:** Skilled nursing (58% NOI), behavioral health
- **Behavioral Health Exposure:** Relevant for UHS valuation

**Industry Context:**
- General healthcare RE cap rates: 6.5-7.5%
- Hospital properties: Premium assets, lower cap rates (6.0-7.0%)
- Behavioral health facilities: Similar to hospitals (6.0-7.0%)

**Recommended Cap Rate for UHS Real Estate:**
- **Behavioral:** 6.0-6.5% (lower = higher value, premium assets)
- **Acute Care:** 6.5-7.0% (hospitals are expensive, premium RE)

---

## üéØ VALUATION BENCHMARKS SUMMARY

### For SOTP Valuation

#### Behavioral Health Operations
- **Conservative:** 8.0x EBITDA (below Acadia's 7.3x due to ACHC depression)
- **Base Case:** 9.5x EBITDA (normalized Acadia + UHS quality premium)
- **Optimistic:** 11.0x EBITDA (historical behavioral multiples pre-2024)

#### Acute Care Operations
- **Conservative:** 6.0x EBITDA (below Tenet, stress scenario)
- **Base Case:** 7.0x EBITDA (Tenet 6.3x + modest premium)
- **Optimistic:** 8.0x EBITDA (closer to industry average 8.1x)

#### Real Estate (Both Segments)
- **Conservative:** 7.0% cap rate (higher cap = lower value)
- **Base Case:** 6.5% cap rate
- **Optimistic:** 6.0% cap rate (lower cap = higher value)

---

## üìä UHS VS PEERS COMPARISON

| Company | EV/EBITDA | Focus | Quality |
|---------|-----------|-------|---------|
| **UHS (current)** | **6.4x** | Acute + Behavioral | Diversified |
| Acadia Healthcare | 7.3x | Behavioral only | Pure-play |
| Tenet Healthcare | 6.3x | Acute only | Comparable |
| HCA Healthcare | 9-10x | Acute only | Premium |
| Industry Average | 8.1x | Acute care | Average |

**Key Insight:** UHS trades at 6.4x blended, BELOW both pure-play comps
- Behavioral worth 8-11x (UHS has $1.57B EBITDA)
- Acute worth 6-8x (UHS has $1.21B EBITDA)
- **Implied blended multiple should be 7.5-9.0x, not 6.4x**
- **Value gap suggests 17-41% upside just from multiple re-rating**

---

## üí° IMPLICATIONS FOR UHS SOTP

### Current Market is Undervaluing UHS

**What Market Implies (at 6.4x EV/EBITDA on $17.76B EV):**
- Treats entire company as one low-multiple business
- Doesn't differentiate high-margin behavioral (22.7%) from lower-margin acute (13.5%)
- Ignores that behavioral generates MORE EBITDA (56%) than acute (44%)
- Does not value owned real estate separately

**What SOTP Should Show:**
- Behavioral segment alone worth $1.57B √ó 9.5x = $14.9B (base case)
- Acute segment alone worth $1.21B √ó 7.0x = $8.5B (base case)
- Owned real estate worth $13-20B at market (vs $6.6B book)
- **Total value significantly higher than $17.76B current EV**

---

**Next Step:** Build detailed SOTP model with these multiples

**Document Version:** 1.0
**Last Updated:** October 27, 2025
